TCG Crossover GP II, LLC sold $6.9M of Surrozen (SRZN)

Executed Jul 22, disclosed Jul 25, 2 days later.

Value, as filed

$6.9M

325,000 sh across 2 lots

Executed

Jul 22

the trade date, as filed

Disclosed

Jul 25

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TL TCG Crossover GP II, LLC 10% owner profile →

TCG Crossover GP II, LLC (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (3 purchases, 1 sale), most often in Surrozen, Inc. (SRZN). Across 3 priced purchase filings, the average 21-session return was +12.8% from execution and +16.1% from disclosure (delay-adjusted; derived). The largest single filing was $6.9M of SRZN (325,000 sh across 2 lots, as filed), executed Jul 22.

The name

SRZN

Surrozen, Inc. SRZN · Healthcare · 16 filings in 24 months ticker →

Healthcare · Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by TCG Crossover GP II, LLC in SRZN

SRZNPURCHASE Surrozen, Inc. $3.0M
121,881 sh across 4 lots
Exec Mar 23
Filed Mar 25 · 8:02 PM ET SRZNPURCHASE Surrozen, Inc. $1.2M
47,807 sh across 4 lots
Exec Mar 12
Filed Mar 16 · 7:05 PM ET SRZNPURCHASE Surrozen, Inc. $419K
17,763 sh across 2 lots
Exec Feb 11
Filed Feb 13 · 4:19 PM ET